Biotech Industry News
A collection of Biotech latest news, analysis and best practices from top business influencers and the world's most trustworthy sources.
Inside Regeneron: How a 32-year-old biotech that fought Ebola and made its founders billionaires is leading the coronavirus-treatment race
Regeneron Pharmaceuticals is at the front of the pack in the race to develop a coronavirus treatment. The company started clinical trials last month for its coronavirus drug, and has said it could be ready this fall. The drug, called an antibody…
Biotech Stocks to Start Building Wealth
Investors in the top biotech stocks have seen some big gains in their portfolios of late. The biotech industry has steadily outpaced the greater volatile market. And whether you look to its past, present or future, these stocks have had an…
Could biotechnology be the vital catalyst to deliver a green economic recovery?
Biotechnology's game-changing role as a catalyst to reboot the economy and build a more sustainable future will be the focus of a summit co-hosted by The University of Manchester. The panel debate and live Q&A is entitled 'Biotechnology: The…
Biogen Stock Is Jumping. The Biotech Submitted Its Troubled Alzheimer's Drug for FDA Approval.
Not so long ago, the saga of Biogen's experimental Alzheimer's therapy aducanumab was, perhaps, the biggest story in biotech. Covid-19 changed all that, driving investor focus to the race for a vaccine. But Biogen is still moving forward with…
Could a coronavirus vaccine rehab the pharmaceutical industry's reputation despite drug price increases?
For years, the pharmaceutical industry has faced withering bipartisan criticism and a deteriorating reputation among the public for its role in driving up drug prices. But the sector suddenly might be poised to go from villain to hero with the…
Coronavirus latest: Brooks Brothers files for bankruptcy
The Nikkei Asian Review is tracking the spread of the new coronavirus that originated in the central Chinese city of Wuhan. Global cases have reached 11,863,477, according to Johns Hopkins University in Baltimore. The worldwide death toll has hit…
Rossari Biotech to launch Rs 500 cr initial public offering on Monday
Specialty chemicals | biotech | IPO Sundar Sethuraman | Mumbai Last Updated at July 8, 2020 17:36 IST The IPO also comprises a secondary share sale of 10.5 million shares by promoters Rossari Biotech, a specialty chemicals company, will launch its…
Rossari Biotech IPO to open on 13 July, price band at ₹423- ₹425 per share
MUMBAI: Specialty chemicals manufacturer Rossari Biotech Limited will launch its initial public offering (IPO) on 13 July with a price band of ₹423- ₹425 per share. The three-day share sale, which will close on 15 July, seeks to raise…
The coronavirus is accelerating protectionist trends and fragmenting global trade
The pandemic will accentuate the deepening uncertainty over the future of global trade, according to a new report. Why it matters: Trade is the lifeblood of globalization, and it's helped lift hundreds of millions of people out of poverty. But…
Fundamentally different' from Portola, Dutch biotech lands €32M to steer anti-anticoagulant through the clinic
Portola may not have had much success proving the commercial value of an anti-anticoagulant, but that's not stopping European investors from pouring $36.2…
Carbon Wheels Market Revenue to Hit USD 450M by 2026; Global Market Insights, Inc.
SELBYVILLE, Del., July 8, 2020 (Newswire.com) - Global Market Insights, Inc. has recently added a new report on the carbon wheels market, which estimates the market valuation for carbon wheels will cross US $450 million by 2026. Increasing premium…
Specialty Chemicals Manufacturer, Rossari Biotech Limited IPO to open on July 13, 2020
Rossari's IPO to open on July 13, 2020 – Initial public offering of [●] equity shares of face value of ₹ 2 each (“ Equity Shares ”) of Rossari Biotech Limited (the “ Company ” or the “ Issuer…
1 year later, first gene edited sickle cell patient is functionally cured
Our interactive GLP global map explains the status of each country's regulations for human and agricultural gene editing and gene drives. This GLP project maps contributions by foundations to anti-biotech activists and compares it to pro-GMO…
Modular Data Center Market Revenue to Hit USD 35B by 2026; Global Market Insights, Inc.
SELBYVILLE, Del., July 8, 2020 (Newswire.com) - Global Market Insights, Inc. has recently added a new report on the modular data center market, which estimates the market valuation for modular data centers will cross US $35 billion by 2026. The…
XBI: Not Everybody Can Be A Hero (NYSEARCA:XBI)
Of all the investable sectors and industries, one of the top-performing over the past few months is biotechnology. Since its March low (18), the SPDR Biotech ETF (XBI) has risen about 75% as investors speculate on virus treatment and vaccine…
Receive a Daily briefing on Biotech Industry News
Learn from targeted reports
Our focused News Reports help you stay up-to-date with any and all of your industry interests